• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表征包涵体肌炎患者肌肉中的局部抗体反应。

Characterizing local antibody responses in the muscle of inclusion body myositis patients.

作者信息

Jayaraman Sahana, Wilson Andrew, Zheng Xuwen Alice, Montagne Janelle M, Pinal-Fernandez Iago, Mammen Andrew L, Lloyd Thomas E, Larman H Benjamin

机构信息

Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

J Autoimmun. 2025 Jun;154:103437. doi: 10.1016/j.jaut.2025.103437. Epub 2025 May 26.

DOI:10.1016/j.jaut.2025.103437
PMID:40424896
Abstract

OBJECTIVE

Sporadic inclusion body myositis (IBM) is the most common adult idiopathic inflammatory myopathy. IBM etiology has been elusive, due to both degenerative and autoimmune disease features found on muscle biopsy, and significant disease heterogeneity. Investigating the role of antibodies in the muscle of IBM patients may improve our understanding of disease pathogenesis.

METHODS

We used an IBM xenograft mouse model in which muscle biopsy tissue from IBM patients (n = 98) and controls (n = 131; including 54 from other types of myopathy) were implanted into immunodeficient mice (NOD-Rag1-IL2rγ). We quantified the amount of human IgG, IgA, and IgM in xenografted mouse sera using MesoScale Diagnostics (MSD) assay. We detected donor-derived antibody reactivities targeting autoantigens and infectious agents using Phage ImmunoPrecipitation Sequencing (PhIP-Seq). Finally, we used FR3 AmplifiKation Sequencing (FR3AK-Seq) to sequence the antibody mRNAs from a separate cohort of 146 patient biopsies (14 IBM, 22 healthy controls, 110 other myositis subtypes).

RESULTS

With the MSD assay we found human IgG, IgA, and IgM in a larger percentage of IBM xenografted mice versus controls. Using PhIP-Seq, we found anti-microbial reactivities secreted from IBM muscle are prevalent amongst a healthy control population but autoantigen reactivities in IBM are more unique at the peptide and protein level. Additionally, NT5C1A (IgG/IgA and IgM) and TIF1γ (IgG/A) autoantibodies are secreted from muscle tissues of 4/18 and 10/18 IBM xenograft donors, respectively.

CONCLUSION

Our characterization of antibody responses within the muscle of IBM patients reveals that muscle-infiltrating B cells produce both disease-associated autoantibodies and a broad spectrum of antibodies targeting non-self antigens.

摘要

目的

散发性包涵体肌炎(IBM)是最常见的成人特发性炎性肌病。由于在肌肉活检中发现了退行性和自身免疫性疾病特征,以及显著的疾病异质性,IBM的病因一直难以捉摸。研究抗体在IBM患者肌肉中的作用可能会增进我们对疾病发病机制的理解。

方法

我们使用了一种IBM异种移植小鼠模型,将IBM患者(n = 98)和对照组(n = 131;包括54例其他类型肌病患者)的肌肉活检组织植入免疫缺陷小鼠(NOD-Rag1-IL2rγ)体内。我们使用MesoScale Diagnostics(MSD)检测法对异种移植小鼠血清中的人IgG、IgA和IgM含量进行了定量。我们使用噬菌体免疫沉淀测序(PhIP-Seq)检测了针对自身抗原和感染因子的供体来源抗体反应性。最后,我们使用FR3扩增测序(FR3AK-Seq)对来自另一组146例患者活检样本(14例IBM患者、22例健康对照、110例其他肌炎亚型患者)的抗体mRNA进行了测序。

结果

通过MSD检测法,我们发现与对照组相比,在更大比例的IBM异种移植小鼠中检测到了人IgG、IgA和IgM。使用PhIP-Seq,我们发现IBM肌肉分泌的抗微生物反应性在健康对照人群中普遍存在,但IBM中的自身抗原反应性在肽和蛋白质水平上更为独特。此外,分别从4/18和10/18例IBM异种移植供体的肌肉组织中分泌出了NT5C1A(IgG/IgA和IgM)和TIF1γ(IgG/A)自身抗体。

结论

我们对IBM患者肌肉中抗体反应的表征表明,肌肉浸润性B细胞产生了与疾病相关的自身抗体以及针对非自身抗原的广谱抗体。

相似文献

1
Characterizing local antibody responses in the muscle of inclusion body myositis patients.表征包涵体肌炎患者肌肉中的局部抗体反应。
J Autoimmun. 2025 Jun;154:103437. doi: 10.1016/j.jaut.2025.103437. Epub 2025 May 26.
2
Interventions for dysphagia in long-term, progressive muscle disease.长期进行性肌肉疾病吞咽困难的干预措施。
Cochrane Database Syst Rev. 2016 Feb 9;2(2):CD004303. doi: 10.1002/14651858.CD004303.pub4.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Mitochondrial pathology in inflammatory myopathies: a marker of worse clinical outcome.炎症性肌病中的线粒体病理学:临床预后较差的一个标志物。
J Neurol. 2025 Jun 26;272(7):480. doi: 10.1007/s00415-025-13192-z.
7
Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.抗-Ku 阳性肌炎:获得性炎症性蛋白聚集体肌病。
Acta Neuropathol. 2024 Jul 16;148(1):6. doi: 10.1007/s00401-024-02765-3.
8
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis.利用人诱导多能干细胞衍生的肌管建立包涵体肌炎模型。
Acta Neuropathol Commun. 2025 Feb 21;13(1):38. doi: 10.1186/s40478-025-01933-0.
9
Muscle Sonography in Inclusion Body Myositis: A Systematic Review and Meta-Analysis of 944 Measurements.包涵体肌炎的肌肉超声:944 项测量的系统评价和荟萃分析。
Cells. 2022 Feb 9;11(4):600. doi: 10.3390/cells11040600.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.包涵体肌炎中针对线粒体呼吸链复合体I一个亚基的自身抗体。
J Autoimmun. 2024 Dec;149:103332. doi: 10.1016/j.jaut.2024.103332. Epub 2024 Nov 18.
2
The Plasma Cell Infiltrate Populating the Muscle Tissue of Patients with Inclusion Body Myositis Features Distinct B Cell Receptor Repertoire Properties.在包涵体肌炎患者的肌肉组织中浸润的浆细胞具有独特的 B 细胞受体库特征。
Immunohorizons. 2023 May 1;7(5):310-322. doi: 10.4049/immunohorizons.2200078.
3
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses.
噬菌体展示环境蛋白毒素和毒力因子揭示了抗体反应的普遍性、持久性和遗传学。
Immunity. 2022 Jun 14;55(6):1051-1066.e4. doi: 10.1016/j.immuni.2022.05.002. Epub 2022 May 31.
4
T cell depletion increases humoral response by favoring T follicular helper cells expansion.T 细胞耗竭通过促进滤泡辅助性 T 细胞的扩增增加体液免疫反应。
Am J Transplant. 2022 Jul;22(7):1766-1778. doi: 10.1111/ajt.17038. Epub 2022 Apr 15.
5
Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.在散发型包涵体肌炎的异种移植物模型中,TDP-43 功能丧失和边缘空泡在 T 细胞耗竭后仍然存在。
Sci Transl Med. 2022 Jan 19;14(628):eabi9196. doi: 10.1126/scitranslmed.abi9196.
6
GIANA allows computationally-efficient TCR clustering and multi-disease repertoire classification by isometric transformation.GIANA 通过等距变换实现计算高效的 TCR 聚类和多疾病库分类。
Nat Commun. 2021 Aug 4;12(1):4699. doi: 10.1038/s41467-021-25006-7.
7
Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients.抗合成酶综合征患者中,Jo-1 自身抗原特异性 B 细胞偏向于不同的功能 B 细胞亚群。
Arthritis Res Ther. 2021 Jan 19;23(1):33. doi: 10.1186/s13075-020-02412-8.
8
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants.从抗合成酶综合征患者中分离单克隆抗体,并通过独立体细胞变异的重组进行亲和力成熟。
MAbs. 2020 Jan-Dec;12(1):1836718. doi: 10.1080/19420862.2020.1836718.
9
Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis.超高效率的 T 细胞受体测序揭示了肌炎患者肌肉中的共同反应。
EBioMedicine. 2020 Sep;59:102972. doi: 10.1016/j.ebiom.2020.102972. Epub 2020 Sep 3.
10
Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.机器学习算法揭示了不同类型肌炎患者肌肉活检中的独特基因表达谱。
Ann Rheum Dis. 2020 Sep;79(9):1234-1242. doi: 10.1136/annrheumdis-2019-216599. Epub 2020 Jun 16.